Navigation Links
Prostate Cancer in Obese Men

Two new studies show obese men with prostate cancer are at a higher risk of developing more aggressive tumors and of experiencing cancer recurrence than men of normal weight.//

The first study conducted by researchers at the Naval Medical Center in San Diego sampled nearly 3,200 prostate cancer patients. In this group, 19 percent of the patients were considered obese -- defined as having a body mass index higher than 30.

Researchers found a correlation between obesity and a higher Gleason score, the value used to classify the aggressiveness of prostate tumors. They also found obese men tended to have a higher cancer recurrence rate.

The second study was conducted by researchers at Johns Hopkins University School of Medicine on nearly 1,100 prostate cancer patients, 22 percent of who were obese. In this study, obesity was defined as a body mass index higher than 35. As in the first study, researchers concluded that obese men also were more like to have a higher Gleason score. Another similar conclusion was that in both studies black men were more likely to be obese.

Stephen J. Freedland, M.D., co-author of the study, says, "We suspect that worse outcomes among African-American men with prostate cancer are related to obesity rather than race."

Researchers for both studies suggest that proteins and hormones stored in body fat -- such as leptin and insulin-like growth factor 1 -- may encourage prostate tumor growth in obese men. Also, obese men usually have lower testosterone levels and higher estrogen levels, which may promote cancer growth. In addition, diets high in fat may promote tumor growth.

Medical peers agree with the conclusions of the studies and encourage further investigation. Alfred I. Neugut, M.D., Ph. D., of Columbia University, says, "The number of prostate cancer survivors is steadily increasing, and it will be important to investigate if weight loss and other lifestyle changes can impr ove prognosis in those already diagnosed with prostate cancer."


'"/>




Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
3. New Prostate Cancer Vaccine Shows Promise
4. Hormone Therapy applicable for Prostate Cancer
5. Prostate cancer and Vitamins
6. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
7. Early Detection Of Prostate Cancer
8. Awareness increase Prostate cancer detection
9. Better Prostate Cancer Test
10. Stopping Prostate Cancer from Spreading
11. Drug might prevent Prostate Cancer Spread
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... ... February 09, 2016 , ... Ross A. Clevens, MD, ... to welcome a new addition to their growing practice. Beginning this month, Teresa ... nurse practitioner performing cosmetic procedures including injectables, fillers and laser treatments. ...
(Date:2/9/2016)... ... February 09, 2016 , ... Steven Douglas Associates is a ... Florida Event, an upscale fundraiser held in South Florida. The Inaugural What’s Your Taste ... This year the event will be held in a new, more causal format at ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... production of its newest mobility device, the StandUp Walker. Made entirely in the ... in the last 50 years. , StandUp Walker’s novel patent-pending design offers 2-in-1 ...
(Date:2/9/2016)... Springs, FL (PRWEB) , ... February 09, 2016 ... ... leading innovative specialty pharmacies, announces today the continuation of the ‘Pay It Forward’ ... for each prescription referral received at our specialty pharmacy. , “Since our ...
(Date:2/9/2016)... ... February 09, 2016 , ... The Bon-Ton Stores, Inc. (NASDAQ: ... stores, announced it has raised $176,000 to benefit the Breast Cancer Research Foundation, ... at the University of Iowa, The Lynn Sage Cancer Research Foundation, and Masonic ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , Feb. 9, 2016 On ... Administration (FDA) met with its Arthritis Advisory ... biosimilar of Johnson & Johnson,s Remicade and ... approved in the U.S. The Biologics Prescribers ... groups - Alliance for Patient Access, American ...
(Date:2/9/2016)... Calif. , Feb. 9, 2016 /PRNewswire/ - Nevro ... company that is providing innovative evidence-based solutions for the ... release financial results for the fourth quarter and full ... 29, 2016. Company management will host a conference call ... Time) on Monday, February 29, 2016. www.nevro.com ...
(Date:2/9/2016)... 9, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... today reported its fourth quarter and full year ... vivo therapeutic genome editing," said Edward Lanphier, ... finger nuclease (ZFN) technology leads the therapeutic genome ... competencies necessary to move our ground-breaking genome editing ...
Breaking Medicine Technology: